- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 14/70 - Enképhalines
Détention brevets de la classe C07K 14/70
Brevets de cette classe: 104
Historique des publications depuis 10 ans
|
5
|
9
|
15
|
11
|
6
|
8
|
15
|
4
|
9
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Immatics Biotechnologies GmbH | 1172 |
17 |
| The Regents of the University of California | 19572 |
4 |
| The Trustees of the University of Pennsylvania | 4273 |
3 |
| Instytut Farmakologii Polskiej Akademii Nauk | 11 |
3 |
| Uniwersytet Warszawski | 142 |
3 |
| Shattuck Labs, Inc. | 112 |
3 |
| Centre National de La Recherche Scientifique | 10140 |
2 |
| The Board of Trustees of the Leland Stanford Junior University | 6259 |
2 |
| Wisconsin Alumni Research Foundation | 3838 |
2 |
| The General Hospital Corporation | 4655 |
2 |
| Albert Einstein College of Medicine, Inc. | 567 |
2 |
| Alpine Immune Sciences, Inc. | 84 |
2 |
| Baylor College of Medicine | 920 |
2 |
| Charite - Universitatsmedizin Berlin | 386 |
2 |
| National Research Council of Canada | 1573 |
2 |
| Inmatics Biotechnologies GmbH | 5 |
2 |
| Instytut Medycyny Doswiadczalnej I Klinicznej Im. | 3 |
2 |
| Artema Therapeutics, Inc. | 4 |
2 |
| Hoffmann-La Roche Inc. | 3280 |
1 |
| Board of Regents, The University of Texas System | 5641 |
1 |
| Autres propriétaires | 45 |